Quotient Sciences

Translational Pharmaceutics®, accelerates development by integrating formulation development, real-time manufacturing and clinical testing.  This integrated approach is proven to reduce timelines by more than 12 months and lower R&D costs by more than $100 million.  Over the past decade ...

From preclinical and first-in-human (FIH) dosage forms to optimization of your drug product for late-stage development and market following clinical evaluation, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your drug molecule, t...

Quotient Sciences provides drug substance synthesis and manufacturing capabilities from candidate selection through to commercial production.  With tactical deployment of best-in-class technologies, we minimize chemistry costs and move your drug substance supply off the critical path. With more than 4...

The acquisition will extend the 12-month drug development timeline savings already delivered by Quotient’s flagship platform Translational Pharmaceutics

Quotient Sciences is a drug development and manufacturing accelerator supporting customers across the entire development pathway from candidate selection to commercial launch. We deliver uniquely integrated programs and a range of tailored services that dramatically shorten drug development times. We’re driven by an unswerving belief that ideas need to become solutions, and molecules need to become cures, fast. Because humanity needs solutions, fast.